Subsequent chemotherapy regimens are well tolerated after radioimmunotherapy with yttrium-90 ibritumomab tiuxetan for non-Hodgkin's lymphoma (Q33344254)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Subsequent chemotherapy regimens are well tolerated after radioimmunotherapy with yttrium-90 ibritumomab tiuxetan for non-Hodgkin's lymphoma |
scientific article |
Statements
1 reference
Subsequent chemotherapy regimens are well tolerated after radioimmunotherapy with yttrium-90 ibritumomab tiuxetan for non-Hodgkin's lymphoma (English)
1 reference
Stephen M Ansell
1 reference
Kay M Ristow
1 reference
Thomas M Habermann
1 reference
Gregory A Wiseman
1 reference
Thomas E Witzig
1 reference
1 September 2002
1 reference
1 reference
20
1 reference
18
1 reference
3885-3890
1 reference
Identifiers
1 reference
1 reference